Catholic World Report

Democratic senators ask Biden administration to mandate coverage of OTC birth control

birth control
Credit: Selbe via Flickr (CC BY-NC-ND 2.0)

A group of Democratic senators is asking the White House to require insurance companies to cover over-the-counter (OTC) hormonal birth control, which was recently approved by federal regulators.

The U.S. Food and Drug Administration in July approved the first nonprescription oral contraceptive, called “Opill.” The drug is expected to be available in pharmacies and online in 2024.

Previously, oral contraceptives required a doctor’s visit and a prescription for women to access them. The FDA’s ruling paves the way for such drugs to be available in pharmacies and drugstores for purchase without any oversight from a doctor.

In their letter last week, the Democratic senators asked the Biden administration to “ensure coverage for OTC contraceptive products” in “all federally and state-regulated private health plans and federally and state-regulated and run coverage programs.”

The senators suggested the administration could add the OTC pill “to an existing coverage requirement and/or formulary” and “eliminate any otherwise-required cost-sharing and prior authorization for OTC contraceptives,” among other approaches.

The Catechism of the Catholic Church explicitly refers to contraception as a “morally unacceptable” form of birth regulation, stating that “every action” that “proposes … to render procreation impossible” is “intrinsically evil.”

The U.S. Conference of Catholic Bishops in July of this year condemned the FDA’s approval of the OTC pill, with Winona–Rochester Bishop Robert Barron stating that the pill’s over-the-counter approval “violates the Hippocratic Oath by putting the health of women at grave risk.”

“This action by a government entity flies in the face of responsible medical practice and concerns for women’s health,” Barron said at the time. He pointed to the “strong evidence of the many harmful risks of hormonal contraception to women’s health.”

Contraception coverage has been a contentious part of U.S. health care policy for years. Following the passage of the Affordable Care Act, the Obama administration mandated broad coverage of contraceptives in health insurance plans, including for policyholders who object to birth control on religious or moral grounds.

In 2020, the Little Sisters of the Poor, a Catholic religious institute organization, won a victory at the U.S. Supreme Court affirming the legality of a “moral exemption” to the coverage that had been asserted by the Trump administration.

The Supreme Court had earlier issued a narrow religious exemption to the mandate for some corporations in the 2014 decision Burwell v. Hobby Lobby Stores, Inc.


If you value the news and views Catholic World Report provides, please consider donating to support our efforts. Your contribution will help us continue to make CWR available to all readers worldwide for free, without a subscription. Thank you for your generosity!

Click here for more information on donating to CWR. Click here to sign up for our newsletter.


About Catholic News Agency 12475 Articles
Catholic News Agency (www.catholicnewsagency.com)

3 Comments

  1. Well, I disagree. If you don’t want to employ contraception, fine and dandy. Just don’t try to prevent others from using it.

  2. A clear example of why this is an “agenda item” for these Senators is that birth control is inexpensive to begin with. An example of forcing their will upon individuals with a conscience.

  3. I agree William. But, it is inexpensive so those who want to use it should pay for it not their employers who object for religious reasons.

Leave a Reply

Your email address will not be published.

All comments posted at Catholic World Report are moderated. While vigorous debate is welcome and encouraged, please note that in the interest of maintaining a civilized and helpful level of discussion, comments containing obscene language or personal attacks—or those that are deemed by the editors to be needlessly combative or inflammatory—will not be published. Thank you.


*